Karnataka receives 120 courses of life-saving Tuberculosis drugs

According to the union health ministry, only around 81 patients are on Delaminid in seven states and union territories.

Published: 13th March 2018 06:36 AM  |   Last Updated: 13th March 2018 06:36 AM   |  A+A-

Express News Service

BENGALURU: Even as Tuberculosis (TB) activists are protesting for access to life-saving drugs Bedaquiline and Delaminid, in the national capital, in the backdrop of the End-TB Summit in Delhi to be held on Tuesday, 120 courses of Bedaquiline reached Bengaluru recently.India has only 1,000 doses of Bedaquiline, obtained as donations from manufacturers for multidrug-resistant tuberculosis (MDR-TB) patients. According to the union health ministry, only around 81 patients are on Delaminid in seven states and union territories. Doctors have written to Prime Minister Narendra Modi to make the drugs accessible to more patients.

The existing MDR-TB drugs like Kanamycin cause hearing loss and these newer drugs are a boon that are available only on conditional access (not available in open market) with the Government of India. At least 120 patients among the 1,000 MDR-TB patients in Karnataka have complex TB who are not responsive to any of the existing drugs and will be put on Bedaquiline. However, Delaminid is yet to reach Karnataka. 
These patients will now be treated in six MDR-TB nodal centres of the state. In Mangaluru, Mysuru, Kalaburagi, Bengaluru, Dharwad and Ballari. TB patients being treated by private practitioners should approach these nodal centres for the drug if their doctors haven’t notified their disease to the government yet. 

Dr Ramachandra Bairy, joint director, Tuberculosis, department of health and family welfare, told The New Indian Express, “A committee will be set up consisting of physicians who will check if Bedaquiline can be given to them. Drugs for MDR TB are extremely expensive and toxic, and a patient cannot bear the costs privately. Doctors have also been trained from the state to treat Delaminid and it will be shortly available. Karnataka is one of the seven states chosen for it.” 

A health department official on the condition of anonymity said, “In 2017, 69,000 TB patients were diagnosed and 1,000 patients were diagnosed with MDR TB. Previously, we did not have the labs to diagnose resistance to fluoroquinolone drugs and second-line injectable drugs. Now, we have three labs in Raichur Institute of Medical Sciences, Kempegowda Institute of Medical Sciences, Hubbali and IRL, Bengaluru. Even if they are found to be resistant to one of these two drugs they are eligible for Bedaquiline.”

Bedaquiline should be given for a maximum of six months on top of the WHO recommended combination treatment regimen. The manufacturer recommends 400 mg daily (4 tablets) for 2 weeks followed by 200 mg 3 times per week for the remaining 22 weeks. “The drugs are given in combination with other drugs not individually. The patients have to be admitted to these centres for first two weeks as they can develop side effects like cardiac arrhythmias that need to be monitored using ECG machines. They need to be meticulously monitored,” the official said.   

Stay up to date on all the latest Karnataka news with The New Indian Express App. Download now

Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.